Knowledge Center
Patent / Jan 01, 1986
Rhodium hydrogenation catalyst
Source:
EP 187436
(Ph3P)2Rh(OMe)NHNH2 is prepd. as a stereospecific catalyst for the hydrogenation of 6-demethyl-6-deoxy-6-methylene-5-hydroxytetracycline (I) into doxycycline. Thus, the catalyst was prepd. by refluxing .48 g (Ph3P)3RdCl with 76 .mu.L H2NNH2 in 20 mL MeOH for 90 min. I.HCl (7.38 g), 25 mg catalyst, and 0.1 g Ph3P in 40 mL MeOH were hydrogenated at 89.degree. and 8 kg/cm2, for 5.5 h to give doxycycline, isolated as the p-toluenesulfonate, in 99.5% purity.
Also in the Knowledge Center
/ Jan 26, 2023
Webinar - Accelerating the Adoption of Continuous Tableting: The Responsibility of a CDMO
Read more
Scientific Article
/ Feb 22, 2017
Webinar - Development by Design: Hovione’s Approach to Spray Drying Process Development
Read more
Scientific Article
/ Feb 22, 2017
Webinar - Physical Characterization of Drugs: avoiding surprises during late development
Read more
Scientific Article